UnknownNot Applicable

Pulse Oximeter Screening in Congenital Heart Disease

Turkey (Türkiye)50,000 participantsStarted 2016-04

Plain-language summary

Pulse oximetry screening of newborn infants increases early detection of critical congenital heart disease and minimises the risk of circulatory collapse before surgery. This study provides an update on the implementation of pulse oximetry screening in Turkey

Who can participate

Age range

1 Day – 5 Days

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Babies within the first 24-72 hours followed up in well baby nurseries * Babies prior to discharge, if discharged before 24 hours of age, * Babies ≤5 days and still followed up in well baby nurseries * Babies born ≥35 gestational weeks Exclusion Criteria: * Babies within the first 12 hours of life * Babies \>5 days of life * Babies with a gestational age of \>35 weeks * Babies with major congenital anomaly except congenial heart disease * Babies who had a prenatal diagnosis of congenital heart disease

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

pulse oximeter positivity

Timeframe: 6 months

Trial details

NCT IDNCT02731248

SponsorDr. Sami Ulus Children's Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-04

Contact for this trial

Dilek Dilli, Assoc Prof

+905422368250

View on ClinicalTrials.gov More Congenital Heart Disease trials

Who can participate

Age range

1 Day – 5 Days

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.